NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,339 | -68.9% | 11,864 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $26,813 | -29.4% | 11,864 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $38,000 | -15.6% | 11,864 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $45,000 | -29.7% | 11,864 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $64,000 | -53.6% | 11,864 | +15.7% | 0.00% | -60.0% |
Q4 2021 | $138,000 | -25.0% | 10,250 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $184,000 | +4.5% | 10,250 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $176,000 | -14.1% | 10,250 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $205,000 | +17.8% | 10,250 | 0.0% | 0.01% | -12.5% |
Q4 2020 | $174,000 | +2.4% | 10,250 | 0.0% | 0.01% | +14.3% |
Q3 2020 | $170,000 | -28.3% | 10,250 | 0.0% | 0.01% | -46.2% |
Q2 2020 | $237,000 | +23.4% | 10,250 | -4.5% | 0.01% | -7.1% |
Q1 2020 | $192,000 | -23.2% | 10,730 | -7.4% | 0.01% | 0.0% |
Q4 2019 | $250,000 | -70.0% | 11,587 | -17.0% | 0.01% | -73.6% |
Q4 2017 | $833,000 | +148.7% | 13,952 | 0.0% | 0.05% | +130.4% |
Q3 2017 | $335,000 | +12.0% | 13,952 | -8.7% | 0.02% | +9.5% |
Q2 2017 | $299,000 | -6.3% | 15,283 | +12.5% | 0.02% | -4.5% |
Q1 2017 | $319,000 | +132.8% | 13,587 | +21.4% | 0.02% | +120.0% |
Q4 2016 | $137,000 | -28.6% | 11,195 | 0.0% | 0.01% | -37.5% |
Q3 2016 | $192,000 | +20.8% | 11,195 | 0.0% | 0.02% | +14.3% |
Q2 2016 | $159,000 | +3.2% | 11,195 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $154,000 | -9.9% | 11,195 | +10.2% | 0.01% | -17.6% |
Q4 2015 | $171,000 | +54.1% | 10,160 | 0.0% | 0.02% | +41.7% |
Q3 2015 | $111,000 | – | 10,160 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |